I82.2 represents a clinical category encompassing the formation of a thrombus (blood clot) or the occurrence of an embolism within the primary venous conduits of the thorax, specifically the vena cava. The superior vena cava (SVC) returns deoxygenated blood from the upper body to the right atrium, while the inferior vena cava (IVC) returns blood from the lower body. Obstruction of these vessels, whether partial or complete, can lead to severe hemodynamic consequences. Superior Vena Cava Syndrome is a frequent manifestation of I82.21, often secondary to malignancy or indwelling medical devices like central venous catheters. Inferior Vena Cava thrombosis (I82.22) is frequently an extension of deep vein thrombosis (DVT) from the iliac or femoral veins, though it may also result from primary abdominal pathologies or congenital anomalies. These conditions carry a high risk for pulmonary embolism (PE) and require urgent diagnostic and therapeutic intervention, typically involving anticoagulation or surgical thrombectomy.
Distinguish between acute and chronic phases for specific coding.
Example: Patient presents with sudden onset of bilateral lower extremity edema and flank pain. Imaging confirms acute inferior vena cava thrombosis (I82.220). This acute episode of care for a high-risk vascular condition requires immediate initiation of therapeutic anticoagulation to prevent further propagation and risk of pulmonary embolism.
Billing Focus: The documentation must specify the acute (0) or chronic (1) nature to map to the 6th character.
Specify the exact anatomical vein within the thoracic cavity.
Example: Diagnosis: Acute embolism and thrombosis of the superior vena cava (I82.210) confirmed by chest CTA. The thrombus extends from the junction of the brachiocephalic veins to the right atrium. Current management includes heparin infusion and monitoring for SVC syndrome.
Billing Focus: The 5th character identifies the superior vena cava (1), inferior vena cava (2), or other thoracic veins (9).
Document the underlying cause or provocative factors.
Example: The patient developed acute inferior vena cava thrombosis (I82.220) secondary to a displaced IVC filter. The patient has a history of factor V Leiden mutation (D68.51) and is currently on long-term anticoagulation (Z79.01).
Billing Focus: Provoked versus unprovoked status impacts the duration of therapy and justifies the use of additional diagnosis codes.
Identify the presence of Superior Vena Cava Syndrome.
Example: Clinical assessment reveals facial swelling, neck vein distention, and headache consistent with Superior Vena Cava Syndrome. Imaging confirms acute thrombosis of the superior vena cava (I82.210) due to compression by a mediastinal mass.
Billing Focus: SVC syndrome is a clinical manifestation that must be documented alongside the thrombus code to reflect clinical severity.
Specify laterality or extension into related veins.
Example: CTA shows acute thrombosis of other thoracic veins (I82.290), specifically the right brachiocephalic and azygos veins. No extension into the superior vena cava is noted. Management involves systemic thrombolysis.
Billing Focus: Use I82.290 for thoracic veins other than the SVC or IVC, such as the azygos or brachiocephalic.
Appropriate for the management of stable acute or chronic vena cava thrombosis where treatment adjustments and monitoring are required.
Used for the initial evaluation of a patient referred for suspected vena cava thrombosis with moderate complexity.
Suitable for routine follow-up of chronic vena cava thrombosis that is stable on medication.
The gold standard for non-invasive diagnosis and monitoring of inferior vena cava thrombosis.
Diagnostic procedure used to map thrombus in the SVC prior to intervention.
Used to evaluate the IVC and its tributaries in complex cases of thrombosis.
The primary procedure for treating acute, symptomatic vena cava thrombosis that does not respond to anticoagulation alone.
Indicated for patients with vena cava thrombosis who have contraindications to anticoagulation.
Often used in chronic vena cava thrombosis or SVC syndrome to restore venous return.
Used to evaluate for superior vena cava or brachiocephalic vein thrombosis.
Required for complex patients with multi-organ involvement or life-threatening complications of vena cava thrombosis.
Used for the emergency or highly complex initial evaluation of acute vena cava thrombosis in the office.